-
BioScrip appoints Rick Smith as CEO, reports Q3 results
ELMSFORD, N.Y. Specialty pharmacy provider BioScrip has promoted its COO, the company said Tuesday.
BioScrip announced that COO Rick Smith was named CEO of the company, effective Jan. 1, replacing current CEO Richard Friedman. After stepping down, Friedman will serve as non-executive chairman of BioScrip’s board.
-
Generics lift Endo’s 3Q
CHADDS FORD, Pa. Strong generic sales helped Endo edge analyst expectations for the third quarter, the company noted.
Net income reached $54.2 million, compared with $49.4 million during the period ended Sept. 30. Net sales jumped 23% to $444.1 million, versus $361 million during the same period a year ago. Analysts had estimated sales of $443.36 million for the quarter.